Document is current

Any future updates will be listed below

Is There a Survival Benefit of First-Line Epidermal Growth Factor Receptor Tyrosine-Kinase Inhibitor Monotherapy Versus Chemotherapy in Patients with Advanced Non-Small-Cell Lung Cancer?: A Meta-Analysis

Crossref DOI link: https://doi.org/10.1007/s11523-015-0373-x

Published Online: 2015-06-20

Published Print: 2016-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark